|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | ||||
| Impairment charges | ||||
| Equity-based compensation | ||||
| Provision for credit losses | ||||
| Amortization of deferred financing fees included in interest expense | ||||
| Write-off of unamortized deferred financing fees | ||||
| (Gain) loss on disposal of property, plant and equipment | ||||
| Gain on de-consolidation of Rwanda Trading Company | ||||
| Mark-to-market adjustments | ||||
| Change in fair value of warrant liabilities | ||||
| Foreign currency transactions | ||||
| Deferred income tax expense (benefit) | ||||
| Other | ||||
| Change in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Derivative assets and liabilities | ||||
| Prepaid expense and other assets | ||||
| Accounts payable | ||||
| Accrued liabilities and other | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Additions to property, plant and equipment | ||||
| Additions to intangible assets | ||||
| Acquisition of business, net of cash acquired | ||||
| Acquisition of equity method investments and non-marketable securities | ||||
| Proceeds from sale of equity method investments and non-marketable securities | ||||
| Acquisition of equity method investments and non-marketable securities, inclusive of cash contributed | ||||
| Proceeds from sale of property, plant and equipment | ||||
| Proceeds from deferred purchase price of sold trade receivables | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Payments on debt | ||||
| Proceeds from debt | ||||
| Payments on supply chain financing program | ||||
| Proceeds from supply chain financing program | ||||
| Proceeds from convertible notes payable | ||||
| Proceeds from convertible notes payable - related party | ||||
| Payment of debt issuance costs | ||||
| Payment of convertible notes payable issuance costs | ||||
| Net proceeds from (repayments of) repurchase agreements | ||||
| Net change in unremitted cash collections from servicing factored receivables | ||||
| Proceeds from exercise of stock options | ||||
| Proceeds from exercise of Public Warrants | ||||
| Proceeds from issuance of common stock | ||||
| Payment of equity issuance costs | ||||
| Payment for purchase of non-controlling interest | ||||
| Payment for taxes for net share settlement of equity awards | ||||
| Net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash | ||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | ||||
| Cash and cash equivalents and restricted cash at beginning of period | ||||
| Cash and cash equivalents and restricted cash at end of period | ||||
| Supplemental non-cash investing and financing activities: | ||||
| Property, plant and equipment acquired but not yet paid | ||||
| Amounts obtained as beneficial interest in sold trade receivables | ||||
| Supplemental cash flow information: | ||||
| Cash paid for interest | ||||
| Cash paid for income taxes, net | ||||
Loading...